Improved outcomes in metastatic germ cell cancer: results from a large cohort study.
Marcus Ulrich HentrichJessica DeboleVindi JurinovicArthur GerlPublished in: Journal of cancer research and clinical oncology (2020)
Compared to data from the original IGCCCG classification system, the outcome of patients with metastatic GCC has considerably improved over time. While the prognosis of intermediate-risk patients is excellent, treatment in the poor-prognosis group remains to be improved.
Keyphrases
- poor prognosis
- end stage renal disease
- germ cell
- long non coding rna
- newly diagnosed
- chronic kidney disease
- small cell lung cancer
- squamous cell carcinoma
- peritoneal dialysis
- prognostic factors
- papillary thyroid
- machine learning
- type diabetes
- patient reported outcomes
- squamous cell
- combination therapy
- artificial intelligence
- deep learning
- insulin resistance
- replacement therapy